Making sure that drugs are released in the affected part of the body and at a specific rate is a huge challenge, because the size of the capsules that deliver these active ingredients is uncontrollable. At Microcaps we developed a patented technology that enables the size control of these microcapsules with Swiss precision, hence they all behave exactly the same. This means we can directly tailor and predict the release profile of a drug. Our solution is also highly relevant for fragrances, flavors and probiotics.
Microcapsules protect active ingredients, for example in drugs, and transport them to their intended destination. These microcapsules are produced in large chemical reactors with huge mixers. Although this process produces many microcapsules, they vary in size. Microcapsules of different sizes have different release profiles, which is particularly problematic when administering drugs.
As it currently stands, we let medication flow through our entire body without really knowing when and where the drug will be released. Healthy body parts are unnecessarily affected by this faulty design of medication delivery, resulting in side effects such as fatigue, hair loss, or even organ failure.
Microcaps’ solution can set release profiles with size-controlled microcapsules, allowing the precise dosage, release and control of active ingredients. For example, we would now be able to extend the release time from 3 to 6 months in cancer medications.
This patented technology is one hundred times faster to produce than conventional methods of production.
The microencapsulation market is estimated at 13 billion. Microcaps’ focus sectors are food, cosmetics, and pharmaceuticals, an estimated market of 8-10 billion.